focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Block Admission Return

8 Apr 2011 12:00

RNS Number : 5802E
Phorm Inc
08 April 2011
 



8 April 2011

 

Phorm, Inc.

 

("Phorm" or the "Company")

 

Block Admission Return

 

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, is

providing an update to its block admission return filed on 8 October 2010 (the "Scheme").

 

For the period from 9 October 2010 to 8 April 2011, Phorm did not issue any securities under the Scheme and has the following balance of unissued securities under the Scheme:

 

Name of Plan

Common Shares Originally Admitted Under The Scheme

Common Shares Issuable Under The Scheme at 8 April 2011

2003 Share Plan

2,450,000

2,342,289

2009 EMI Option Plan

250,000

250,000

TOTAL

2,700,000

2,592,289

 

As of 8 October 2010, the Company had an issued share capital of 18,479,907 common shares with a par value of $0.001 each, of which 17,582,569 are trading on AIM under the ticker PHRM, the restricted line and 897,338 are trading on AIM under the ticker PHRX, the unrestricted Line. A further 45,000 common shares are held in treasury.

 

About Phorm:

 

Phorm is a global personalisation technology company that makes content and

advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience. Phorm's partners include leading ISPs, Publishers, Ad Networks and Advertisers.

 

Phorm is a Delaware, US incorporated company, with offices in Seoul, Moscow, Sao

Paulo and London. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 150 employees and direct contractors. For more information, please visit: www.phorm.com

 

Enquiries:

 

Phorm, Inc.

Andy Croxson (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

 

Mirabaud Securities LLP +44 20 7321 2508

(Broker)

Jason Woollard

Peter Krens

 

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Advisor)

Mark Williams

Andrew Chubb

 

About Phorm:

 

Phorm is a global personalisation technology company that makes content and

advertising more relevant to the consumer. Phorm's innovative platform preserves

user privacy and delivers a more interesting online experience. Phorm's partners

include leading ISPs, Publishers, Ad Networks and Advertisers.

 

Phorm is a Delaware, US incorporated company, with offices in Seoul, Moscow, Sao

Paulo and London. The Company was admitted to the AIM market of the London

Stock Exchange in 2004. For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWRRRABASRAR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.